Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
WRBY vs EYE
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
WRBY vs EYE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Specialty Retail |
| Market Cap | $3.34B | $1.81B |
| Revenue (TTM) | $891M | $1.99B |
| Net Income (TTM) | $1M | $30M |
| Gross Margin | 53.4% | 56.5% |
| Operating Margin | -0.7% | 3.0% |
| Forward P/E | 56.7x | 32.6x |
| Total Debt | $233M | $695M |
| Cash & Equiv. | $286M | $39M |
WRBY vs EYE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | 100 | 51.3 | -48.7% |
| National Vision Hol… (EYE) | 100 | 40.2 | -59.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WRBY vs EYE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WRBY is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 13.0%, EPS growth 107.7%, 3Y rev CAGR 13.4%
- Lower volatility, beta 2.22, Low D/E 63.4%, current ratio 2.35x
- 13.0% revenue growth vs EYE's 9.0%
EYE carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.62
- -18.0% 10Y total return vs WRBY's -50.1%
- Beta 1.62, current ratio 0.55x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs EYE's 9.0% | |
| Value | Lower P/E (32.6x vs 56.7x) | |
| Quality / Margins | 1.5% margin vs WRBY's 0.2% | |
| Stability / Safety | Beta 1.62 vs WRBY's 2.22 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +68.3% vs EYE's +46.3% | |
| Efficiency (ROA) | 1.5% ROA vs WRBY's 0.2%, ROIC 3.0% vs -1.3% |
WRBY vs EYE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WRBY vs EYE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EYE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EYE is the larger business by revenue, generating $2.0B annually — 2.2x WRBY's $891M. Profitability is closely matched — net margins range from 1.5% (EYE) to 0.2% (WRBY). On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $891M | $2.0B |
| EBITDAEarnings before interest/tax | $32M | $153M |
| Net IncomeAfter-tax profit | $1M | $30M |
| Free Cash FlowCash after capex | $39M | $73M |
| Gross MarginGross profit ÷ Revenue | +53.4% | +56.5% |
| Operating MarginEBIT ÷ Revenue | -0.7% | +3.0% |
| Net MarginNet income ÷ Revenue | +0.2% | +1.5% |
| FCF MarginFCF ÷ Revenue | +4.4% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.3% | +15.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.5% | +111.3% |
Valuation Metrics
EYE leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 61.7x trailing earnings, EYE trades at a 97% valuation discount to WRBY's 2076.3x P/E. On an enterprise value basis, EYE's 16.2x EV/EBITDA is more attractive than WRBY's 73.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.3B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | 2076.34x | 61.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 56.75x | 32.60x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 73.08x | 16.20x |
| Price / SalesMarket cap ÷ Revenue | 3.83x | 0.91x |
| Price / BookPrice ÷ Book value/share | 9.25x | 2.12x |
| Price / FCFMarket cap ÷ FCF | 76.32x | 24.68x |
Profitability & Efficiency
EYE leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
EYE delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $0 for WRBY. WRBY carries lower financial leverage with a 0.63x debt-to-equity ratio, signaling a more conservative balance sheet compared to EYE's 0.80x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs WRBY's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +0.4% | +3.5% |
| ROA (TTM)Return on assets | +0.2% | +1.5% |
| ROICReturn on invested capital | -1.3% | +3.0% |
| ROCEReturn on capital employed | -1.0% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.63x | 0.80x |
| Net DebtTotal debt minus cash | -$53M | $656M |
| Cash & Equiv.Liquid assets | $286M | $39M |
| Total DebtShort + long-term debt | $233M | $695M |
| Interest CoverageEBIT ÷ Interest expense | — | 3.54x |
Total Returns (Dividends Reinvested)
WRBY leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WRBY five years ago would be worth $4,992 today (with dividends reinvested), compared to $4,462 for EYE. Over the past 12 months, WRBY leads with a +68.3% total return vs EYE's +46.3%. The 3-year compound annual growth rate (CAGR) favors WRBY at 31.0% vs EYE's 0.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +20.2% | -12.0% |
| 1-Year ReturnPast 12 months | +68.3% | +46.3% |
| 3-Year ReturnCumulative with dividends | +125.0% | +2.2% |
| 5-Year ReturnCumulative with dividends | -50.1% | -55.4% |
| 10-Year ReturnCumulative with dividends | -50.1% | -18.0% |
| CAGR (3Y)Annualised 3-year return | +31.0% | +0.7% |
Risk & Volatility
Evenly matched — WRBY and EYE each lead in 1 of 2 comparable metrics.
Risk & Volatility
EYE is the less volatile stock with a 1.62 beta — it tends to amplify market swings less than WRBY's 2.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WRBY currently trades 87.7% from its 52-week high vs EYE's 76.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.22x | 1.62x |
| 52-Week HighHighest price in past year | $31.00 | $30.02 |
| 52-Week LowLowest price in past year | $14.96 | $14.38 |
| % of 52W HighCurrent price vs 52-week peak | +87.7% | +76.0% |
| RSI (14)Momentum oscillator 0–100 | 46.6 | 40.8 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 1.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates WRBY as "Buy" and EYE as "Buy". Consensus price targets imply 54.2% upside for EYE (target: $35) vs 7.8% for WRBY (target: $29).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $29.33 | $35.20 |
| # AnalystsCovering analysts | 15 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% |
EYE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WRBY leads in 1 (Total Returns). 1 tied.
WRBY vs EYE: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is WRBY or EYE a better buy right now?
For growth investors, Warby Parker Inc.
(WRBY) is the stronger pick with 13. 0% revenue growth year-over-year, versus 9. 0% for National Vision Holdings, Inc. (EYE). National Vision Holdings, Inc. (EYE) offers the better valuation at 61. 7x trailing P/E (32. 6x forward), making it the more compelling value choice. Analysts rate Warby Parker Inc. (WRBY) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WRBY or EYE?
On trailing P/E, National Vision Holdings, Inc.
(EYE) is the cheapest at 61. 7x versus Warby Parker Inc. at 2076. 3x. On forward P/E, National Vision Holdings, Inc. is actually cheaper at 32. 6x.
03Which is the better long-term investment — WRBY or EYE?
Over the past 5 years, Warby Parker Inc.
(WRBY) delivered a total return of -50. 1%, compared to -55. 4% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: EYE returned -18. 0% versus WRBY's -50. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WRBY or EYE?
By beta (market sensitivity over 5 years), National Vision Holdings, Inc.
(EYE) is the lower-risk stock at 1. 62β versus Warby Parker Inc. 's 2. 22β — meaning WRBY is approximately 37% more volatile than EYE relative to the S&P 500. On balance sheet safety, Warby Parker Inc. (WRBY) carries a lower debt/equity ratio of 63% versus 80% for National Vision Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WRBY or EYE?
By revenue growth (latest reported year), Warby Parker Inc.
(WRBY) is pulling ahead at 13. 0% versus 9. 0% for National Vision Holdings, Inc. (EYE). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to 107. 7% for Warby Parker Inc.. Over a 3-year CAGR, WRBY leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WRBY or EYE?
National Vision Holdings, Inc.
(EYE) is the more profitable company, earning 1. 5% net margin versus 0. 2% for Warby Parker Inc. — meaning it keeps 1. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EYE leads at 3. 1% versus -0. 6% for WRBY. At the gross margin level — before operating expenses — EYE leads at 54. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WRBY or EYE more undervalued right now?
On forward earnings alone, National Vision Holdings, Inc.
(EYE) trades at 32. 6x forward P/E versus 56. 7x for Warby Parker Inc. — 24. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 54. 2% to $35. 20.
08Which pays a better dividend — WRBY or EYE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is WRBY or EYE better for a retirement portfolio?
For long-horizon retirement investors, National Vision Holdings, Inc.
(EYE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Warby Parker Inc. (WRBY) carries a higher beta of 2. 22 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EYE: -18. 0%, WRBY: -50. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WRBY and EYE?
These companies operate in different sectors (WRBY (Healthcare) and EYE (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.